Mode of action of glucocorticoids;Mode d'action des glucocorticoides

Presse Medicale

Volumn 29, Issue 4, 2000, Pages 215-223

  Biola, A ^a   Pallardy, M ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; DNA; IMMUNOSUPPRESSIVE AGENT; STEROID;

CORTICOSTEROID THERAPY; GENE EXPRESSION REGULATION; GENE TARGETING; HORMONE RECEPTOR INTERACTION; NUCLEOTIDE SEQUENCE; REVIEW; APOPTOSIS; COMPARATIVE STUDY; DRUG EFFECT; GENETIC TRANSCRIPTION; GENETICS; HUMAN; IMMUNE SYSTEM;

ANTI-INFLAMMATORY AGENTS; ANTINEOPLASTIC AGENTS, HORMONAL; APOPTOSIS; DNA; GENE EXPRESSION REGULATION; GLUCOCORTICOIDS; HUMANS; IMMUNE SYSTEM; IMMUNOSUPPRESSIVE AGENTS; RECEPTORS, GLUCOCORTICOID; STEROIDS; TRANSCRIPTION, GENETIC;

EID: 0034606837     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (49)

1. Boutin F, Lagorce JF, Marquet P et al. Les glucocorticoïdes. Lyon Pharmaceutique 1995 ; 46: 203-309.
2. Schimmer BP, Parker KL. Adrenocorticotropic hormone; adrenocortical steroids and their synthetic analogs; inhibitors of the synthesis and actions of adrenocortical hormones. In The pharmacological basis of therapeutics. Eds Goodman & Gilman 1996 ; 1459-85.
3. Freedman LP, Luisi BF, Korszun RZ et al. The function and structure of the metal coordination sites within the glucocorticoid receptor DNA binding domain. Nature 1988 ; 334:543-6.
4. Muller M, Renkawitz R. The glucocorticoid receptor. Biochim Biophy Act 1991 ; 1088:171-82.
5. Danielsen M, Hinck L, Ringold GM. Two amino acids within the knuckle of the first zinc finger specify DNA response element activation by the glucocorticoid receptor. Cell 1989 ; 57:1131-8.
6. Picard D, Yamamoto KR. Two signals mediate hormone dependent nuclear localization of the glucocorticoid receptor. EMBO J 1987 ; 6:3333-40.
7. Cadepond F, Gasc JM, Delahaye F et al. Hormonal regulation of the nuclear localization signals of the glucocorticosteroid receptor. Exp Cell Res 1992 ; 201:99-108.
8. Bolander FF. Nuclear receptors. In: Molecular endocrinology. Academic Press, 1994 ; 118-48.
9. Zhang S, Liang X, Danielsen M. Role of the C terminus of the glucocorticoid receptor in hormone binding and agonist/antagonist discrimination. Mol Endocrinol 1996 ; 10:24-34.
10. Hollenberg SM, Giguere V, Segui P, Evans RE. Colocalization of DNA-binding and transcriptional activation functions in the human glucocorticoid receptor Cell 1987 ; 49:39-46.
11. Miesfeld R, Godowski PJ, Maler BA, and Yamamoto KR. Glucocorticoid receptor mutants that define a small region sufficient for enhancer activation. Science 1987 ; 236:423-7.
12. Picard D, Salser SJ, Yamamoto KR. A movable and regulable inactivation function within the steroid binding domain of the glucocorticoid receptor. Cell 1988 ; 54:1073-80.
13. Pratt WB, Toft DO. Steroid receptor interactions with heat shock protein and immunophilin chaperones. Endocrine Reviews 1997 ; 18:306-60.
14. Hutchinson KA, Czar MJ, Scherrer LC, Pratt WB. Monovalentication selectivity for ATP-dependent association of the glucocorticoid receptor with hsp 70 and hsp 90. J Biol Chem 1992 ; 267:14047-53.
15. Chen S, Prapapanich V, Rimerman RA, Honoré B, Smith DF. Interaction of p60, a mediator of progesterone receptor assembly, with heat shock proteins hsp90 and hsp 70. Mol Endocrinol 1993 ; 10: 682-93.
16. Johnson JL, Toft DO. Binding of p23 and hsp 90 during assembly with the progesterone receptor. Mol Endocrinol 1995 ; 9:670-8.
17. Dittmar KD, Demady DR, Stancato LF, Krishna P, Pratt WB. Folding of the glucocorticoid receptor by the heat shock protein (hsp) 90-based chaperone machinery. J Biol Chem 1997 ; 272:21213-20.
18. Galigniana MD, Scruggs JL, Herrington J et al. Heat Shock protein 90-dependent (geldanamycin-inhibited) movement of the glucocorticoid receptor through the cytoplasm to the nucleus requires intact cytoskeleton. Mol Endocrinol 1998 ; 12:1903-13.
19. Yang J, DeFranco DB. Assessment of glucocorticoid receptor-heat shock protein 90 interactions in vivo during nucleocytoplasmic trafficking. Mol Endocrinol 1996 ; 10:3-13.
20. Savory JGA, Hsu B, Laquian IR. Discrimination between NL1- and NL2-mediated nuclear localization of the glucocorticoid receptor. Mol Cell Biol 1999 ; 19:1025-37.
21. Sackey F, Haché R, Reich T, Kwast-Welfeld J, Lefebvre YA. Determinants of subcellular distribution of the glucocorticoid receptor. Mol Endocrinol 1996 ; 10:1191-1205.
22. Tang Y, DeFranco DB. ATP-dependent release of glucocorticoid receptors from the nuclear matrix. Mol Cell Biol 1996 ; 16:1989-2001.
23. Spector DL. Macromolecular domains within the cell nucleus. Annu Rev Cell Biol 1993 ; 9:265-315.
24. DeFranco DB. Subcellular and subnuclear trafficking of steroid receptor. In: Molecular Biology of Steroid and Nuclear Hormone Receptors. Freedman LP ed. Birkhäuser, Boston, 1998, 19-34.
25. Barrack ER, Coffey DS. The specific binding of estrogens and androgens to the nuclear matrix of sex responsive tissues. J Biol Chem 1980 ; 255:7265-75.
26. Tang Y, Getzenberg RH, Vietmeier BN et al. The DNA-binding and tau2 transactivation domains of the rat glucocorticoid receptor constitute a nuclear matrix-targeting signal. Mol Endocrinol 1998 ; 12:1420-31.
27. Hu J-M, Bodwell JE, Munck A. Control by basal phosphorylation of cell cycle-dependent, hormone-induced glucocorticoid receptor hyperphosphorylation. Mol Endocrinol 1997 ; 11:305-11.
28. Krstic M, Rogatsky I, Yamamoto KR, Garabedian MJ. Mitogen-activated and cyclin-cependent protein kinases selectively and differentially modulate transcriptional enhancement by the glucocorticoid receptor. Mol Cell Biol 1997 ; 17:3947-54.
29. Drouin J, Lin Sun Y, Chamberland M et al. Novel glucocorticoid receptor complex with DNA element of the hormone-repressed POMC gene. EMBO J 1993 ; 12:14556.
30. Cairns C, Carlstedt-Duke J, Gustsfsson J-A. Functional organization of the glucocorticoid receptor. In: Glucocorticoid receptor structure and leukemic cell responses. ed. Bahiru Gametchu, 1995, 1-31.
31. Yang-Yen H-F, Chambard J-C, Sun Y-L et al. Transcriptional interference between c-Jun and the glucocorticoid receptor : mutual inhibition of DNA binding due to direct protein-protein interaction. Cell 1990 ; 62:1205-15.
32. Schule R, Rangarajan P, Kliewer S et al. Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptor. Cell 1990 ; 62:1217-25.
33. Jonat C, Rahmsdorf HJ, Park K-K et al. Antitumor promotion and antiinflammation : down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone. Cell 1990 ; 62:1189-1204.
34. Caldenhoven E, Liden J, Wissink S et al. Negative cross-talk between RelA and the glucocorticoid receptor: a possible mechanism for the antiinflammatory action of glucocorticoids. Mol Endocrinol 1995 ; 9:401-12.
35. Auphan N, DiDonato JA, Rosette C, Helmberg A, Karin M. Immunosuppression by glucocorticoids: inhibition of NFkB activity through induction of IkB synthesis. Science 1995 ; 270:286-90.
36. Lechner J, Welte T, Tomasi JK et al. Promoter dependent synergy between glucocorticoid receptor and STAT5 in the activation of b-casein gene transcription. J Biol Chem 1997 ; 272:20954-60.
37. Stoecklin E, Wissler M, Moriggl R, Groner B. Specific DNA binding of STAT 5, but not of glucocorticoid receptor, is required for their functional cooperation in the regulation of gene transcription. Mol Cell Biol 1997 ; 17:6708-16
38. Gelman G, Staels B, Auverx J. Rôle des co-facteurs transcriptionnels dans le transduction des signaux hormonaux par les récepteurs nucléaires. Med/Sci 1997; 13:961-70.
39. Barnes PJ, Adcock I. Anti-inflammatory actions of steroids: molecular mechanisms. Trends Pharmacol Sci 1993 ; 14:436-41.
40. Goulding NJ, Guyre PM. Glucocorticoids, lipocortins and the immune response. Curr Op Immunol 1993 ; 5:108-13.
41. Hochstrasser M. Protein degradation or regulation: ub the judge. Cell 1996 ; 84:813-5.
42. Scheinman RI, Cogswell PC, Lofquist AK, Baldwin Jr AS. Role of transcriptional activation of IkBa in mediation of immunosuppression by glucocorticoids. Science 1995 ; 270:283-6.
43. Heck S, Bender K, Kullmann M, Göttlicher M et al. IkBα-independent downregulation of NFκB activity by glucocorticoid receptor. EMBO J 1997 ; 16:4698-707.
44. Paliogianni F, Raptis A, Ahuja SS, Najjar SM, Boumpas DT. Negative transcriptional regulation of human interleukin 2 (IL-2) gene by glucocorticoids through interference with nuclear transcription factors AP-1 and NFAT. J Clin Invest 1993 ; 91:1481-9.
45. Boumpas DT, Anastassiou ED, Older SA et al. Dexamethasone inhibits human interleukin 2 but not interleukin 2 receptor gene expression in vitro at the level of nuclear transcription. J Clin Invest 1991 ; 87:1739-47.
46. Cippitelli M, Sica A, Viggiano V et al. Negative transcriptional regulation of the interferon-g promoter by glucocorticoids and dominant negative mutants of c-Jun. J Biol Chem 1995 ; 270:12548-56.
47. Wargnier A, Lafaurie C, Legros-Maida S et al. Down-regulation of human granzyme B expression by glucocorticoids. Dexamethasone inhibits binding to the Ikaros and AP-1 regulatory elements of the granzyme B promoter. J Biol Chem 1998 ; 273:35226-31.
48. Chapman MS, Askew DJ, Kuscuoglu U, Miesfeld RL. Transcriptional control of steroid-regulated apoptosis in murine thymoma cells. Mol Endocrinol 1996 ; 10:967-78.
49. Vayssière BM, Dupont S, Choquart A et al. Synthetic glucocorticoids that dissociate transactivation and AP-1 transrepression exhibit antiinflammatory activity in vivo. Mol Endocrinol 1997 ; 11:1245-55.